Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Endocrinology | Family Medicine
Search Medical Condition
Diabetes Mellitus, Type 2 Clinical Trials
A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (993) clinical trials
Diabetes
Do you or someone you know suffer from Diabetes? Are you taking Metformin or are Naïve to Diabetes medications? If so, you may be eligible to participate in a research study for an investigational Diabetes medication If you qualify you will receive all study-related examinations, lab work and study medications ...
A 26-Week Randomized, Open-label, Active Controlled, Parallel-group, Study Assessing the Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin ± Pioglitazone, Followed by a Fixed Ratio Combination Single-arm 26-Week Extension Period
The maximum duration for GLP1-RA patients will be approximately 29 weeks: an up to 2 week screening period, a 26 week treatment period (either randomized or uncontrolled), and a 3 or 9 day post-treatment safety followup period. Maximum duration for FRC patients will be approximately 55 weeks: an up to ...
Diabetes Mellitus Types I and II
Rapid Medical Research is looking for Type 1 or Type 2 Diabetics to take part in a research study.
This study is designed to evaluate the dose range for MEDI0382 with respect to blood glucose control and weight loss effects, as well as to further explore the safety profile of MEDI0382.
A Phase IIb, Randomised, Parallel, Double-Blind Placebo-Controlled and Open-Label Active Comparator Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes Mellitus This study is designed to evaluate the dose range for MEDI0382 with respect to blood glucose control ...
Diabetic Neuropathy in Type 1 and 2 Diabetics
Northern California Research is conducting a study for diabetic peripheral neuropathy (DPN). DPN is a type of nerve damage that can occur if you have diabetes. This study is for men and women who are experiencing painful diabetic peripheral neuropathy in both lower extremities (legs). The specific events that result ...
Kidney Disease in Type 2 Diabetics
Diabetics are at a higher risk for chronic kidney disease since high blood sugar levels caused by diabetes damage blood vessels in the kidneys. If the blood sugar level remains high over many years, this damage gradually reduces the function of the kidneys. Your kidneys filter wastes and excess fluids ...
Type 2 Diabetes with High Triglycerides
Don’t let diabetes lead to heart problems. Lend a hand to help us research a potential medication that might prevent them. The PROMINENT Study is researching a potential new medication (study drug) for people with type 2 diabetes and elevated triglycerides (a type of fat in the blood) to see ...
Do you have Type II diabetes?
Researchers at the University of Kentucky are inviting you to participate in a study investigating ways to prevent diabetes or obesity. This study will involve a one-time blood draw.
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
The aim of the study is to investigate the longterm impact on cardiovascular morbidity, mortality and renal function of treatment with linagliptin in a selected population of patients with T2DM and to compare outcomes against placebo, on a background of standard of care.
"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors"
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study in overweight and obese subjects with CV disease and/or multiple CV risk factors.
